This study compares the cost-effectiveness of the 4 most common empiric antimicrobial regimens used for the treatment of adults with Community-Acquired Pneumonia CAP at a community health system during a 6-month period. Associations between initial antimicrobials and total hospital costs were determined. Cost-effectiveness ratios were determined by dividing the total...
In this article Millennium Pharmaceuticals, Inc. discusses the CLEAR Platelets Clopidogrel Loading with Eptifibatide to Arrest the Reactivity of Platelets trial, the addition of INTEGRILIN, a potent glycoprotein GP IIb-IIIa inhibitor, to a commonly used antiplatelet regimen provided superior platelet inhibition and prevention of heart muscle damage associated with elective...
Centocor, Inc. announced today that the U.S. Food and Drug Administration FDA has approved an expanded label for REMICADE® infliximab in combination with methotrexate REMICADE regimen, as a first line regimen to treat patients with moderate to severe rheumatoid arthritis RA. The expanded label eliminates the requirement that patients...
In September 2000, two instances of life-threatening hepatotoxicity were reported in health-care workers taking nevirapine NVP for postexposure prophylaxis PEP after occupational human immunodeficiency virus HIV exposure. This report summarizes the results of that analysis and indicates that healthy persons taking abbreviated 4-week NVP regimens for PEP are at risk...
WASHINGTON, Jan. 25 /U.S. Newswire/ -- Today, the U.S. Food and Drug Administration FDA announced the tentative approval of an AIDS drug regimen manufactured in South Africa for the treatment of HIV-1 in adults. This approval clears the way for the procWASHINGTON, Jan. 25 /U.S. Newswire/ -- Today, the U.S....
PRINCETON, N.J. & FOSTER CITY, Calif. -- Bristol-Myers Squibb Company (NYSE:BMY) and Gilead Sciences, Inc. (Nasdaq:GILD) today announced the submission of a New Drug Application NDA to the U.S. Food and Drug Administration FDA for approval of a product that combines the anti-HIV medications SustivaR efavirenz, manufactured by Bristol-Myers Squibb,...
New Data Show Hypertensive Patients Taking Norvasc-Based Regimen Achieved Better Central Blood Pressure Control Central Blood Pressure Shown to Be an Independent Predictor of Cardiovascular ...
Pfizer's Maraviroc, Novel Medicine For HIV, Significantly Reduces Viral Load, in Combination Therapy Across Range of Treatment-Experienced Patients Pivotal Data Presented at the 14th Conference on Retroviruses and Opportunistic ...
The diet landscape has become increasingly confusing as consumers choose among a range of regimens from low-fat to high-protein. As a consequence, those running onsite cafes increasingly am being asked to provide dishes consistent with each of thes The diet landscape has become increasingly...
Dear M&F, I wanted to run my back training workout [at right] by you. The results I've been seeing recently are decent, but I'm still lacking the size and thickness I've always wanted in my back. My chest has always been good, but my back, which is nicely...
Managed Health Care Associates, Inc. MHA, Florham Park, N.J. the largest Alternate Site Group Purchasing Organization GPO in the country, has announced the immediate availability of a database conversion utility in RxPertise Consulting Software, Version 7.5. RxPertise is the largest commercially available Medication Regimen Review MRR software for consultant pharmacists...
What will they think of next? We'll tell you what: gum that burns fat. For real. The brainchild of Professional Personal Trainers Association founder Joe Antouri, FitGum is an idea that makes you wonder why you didn't think of it first. Which means, a very good one. ...
NEW YORK -- ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that the first patient has been treated in its disease-directed Phase 2 clinical trial of IMC-1121B in patients with advanced ovarian cancer. IMC-1121B is ImClone's proprietary...
First-Line Chemotherapy Regimen Showed Clinically Relevant Survival Differences in Specific Histology Types of Advanced Non-Small Cell Lung Cancer INDIANAPOLIS, Sept. 29 /PRNewswire-FirstCall/ -- Eli Lilly and Company announced today it received approval from the U.S. Food and Drug Administration FDA for the use of ALIMTAR (pemetrexed...
Supplements not the basis for good nutrition By Ed Blonz, Ph.D. DEAR DR. BLONZ: I have a long workday and often don't leave the office until it's time for dinner. I am not questioning the importance of eating grains, fruits and vegetables, but I...
NEW YORK, Sept. 29 /PRNewswire/ -- More and more cancer patients are looking for treatment options that allow them to maintain their quality of life during difficult treatment regimens. (See video from Philips at: http://media.medialink.com/WebNR.aspx?story=35774) Philips Research is developing a new ultrasound-based drug delivery...
Baron Davis joins Jenny Craig to get into game shape and lead a nation to better health CARLSBAD, Calif., Sept. 26 /PRNewswire/ -- Jenny Craig Inc., one of the nation's leading authorities on weight management, announced today that pro-basketball star Baron Davis is the company's newest "star"...
EMERYVILLE, Calif., Sept. 25 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTIR) today announced that previously found excess symptomatic intracranial hemorrhage in an earlier European trial of ancrod (now ViprinexTM) for the treatment of acute ischemic stroke may be minimized with avoidance of prolonged low levels of fibrinogen and use...
CAMBRIDGE, Mass. -- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that key data on sustained viral response SVR rates in both treatment-naove and treatment-failure genotype 1 hepatitis C HCV patients who received telaprevir-based treatment regimens will be presented at the 59th Annual Meeting of the American Association for the Study...
Powerful, Dell is built to fit your business needs Customized systems, experts trained in small business, 24/7/365 support, and powerful, reliable technology. Dell, big results for small business.
With AT&T Tech Support 360, you'll have certified, U.S. based technicians on call 24/7 to help keep your computers, connections, software and peripherals up to speed for just 82¢ a day.
